Empowerment-based Complementary and Alternative Medicine (ECAM)

NCT ID: NCT06317584

Last Updated: 2025-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-17

Study Completion Date

2025-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this phase study are to (1) implement the ECAM educational app to empower patients with diabetes in their management of diabetes alongside CAM use; (2) examine the impact of the ECAM educational app on patient empowerment, CAM health literacy, risk management of CAM use, CAM communication and diabetes quality of life in patients with diabetes; and (3) collect feedback from both patients and nurses on how to improve the ECAM educational app for dissemination and implementation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized trail method
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
The process of keeping the study group assignment hidden after the allocation to participant, care provider, investigator, outcomes assessor

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Empowerment Application for CAM Health Education.

Using empowerment software applications for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of the assistive tool of the empowerment software application

Group Type EXPERIMENTAL

Experimental: Empowerment Application for CAM Health Education

Intervention Type OTHER

Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application

Written Paper for CAM Health Education.

Using written paper for complementary and alternative therapy education, explaining the risk factors that need to be considered

Group Type PLACEBO_COMPARATOR

Written Paper for CAM Health Education

Intervention Type OTHER

Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental: Empowerment Application for CAM Health Education

Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application

Intervention Type OTHER

Written Paper for CAM Health Education

Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People over the age of 20
* diagnosis of diabetes at least 12 months before the interview; and
* The use of CAM at least 3 months
* Sufficient mental ability to understand the informed consent form and sign it.

Exclusion Criteria

* Participants will be excluded by an assistant researcher if they serious physical condition and hard of hearing and seeing.
Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Science and Technology Council

FED

Sponsor Role collaborator

Chang Gung Memorial Hospital

OTHER

Sponsor Role collaborator

Chang Gung University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hsiao-Yun Chang

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chang Hsiao Yun, PhD

Role: STUDY_CHAIR

Chang Gung University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHENG GUNG MEMORIAL HOSPITAL, Linkou

Taoyuan, Guishan District, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NMRPF3M0042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.